Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Opdivo
Pharma
BMS follows Roche, AstraZeneca into first-line liver cancer
With the nod, BMS' Opdivo and Yervoy will go toe-to-toe with Roche's Tecentriq-Avastin and AstraZeneca's Imfinzi-Imjudo in first-line liver cancer.
Angus Liu
Apr 11, 2025 1:53pm
Exelixis shifts focus as triplet misses OS mark in kidney cancer
Feb 18, 2025 1:30pm
BMS’ Opdualag flunks trial as adjuvant for resected melanoma
Feb 14, 2025 8:15am
After $1.5B cost-cutting plan, BMS will cut an additional $2B
Feb 6, 2025 8:33am
BMS, Pfizer tout new standards in colorectal cancer subtypes
Jan 25, 2025 3:00pm
FDA approves BMS' subcutaneous Opdivo with some limitations
Jan 2, 2025 9:15am
